Benefits and risks of inhaled glucocorticoids in children with persistent asthma

被引:24
作者
Simons, FER [1 ]
机构
[1] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada
关键词
D O I
10.1016/S0091-6749(98)70035-1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
In children, an inhaled glucocorticoid is currently the medication of choice for the long-term control of persistent asthma, Inhaled glucocorticoids are significantly more effective than nonsteroidal medications on all outcome measures of asthma treatment. They reduce the frequency of symptoms and of acute asthma exacerbations, decrease the need for "rescue" medications, improve airway patency, and reduce airway hyperresponsiveness. These considerable long-term benefits are worth the minimal risks of clinically significant local ol systemic adverse effects. An inhaled glucocorticoid should be used in the lowest dose that prevents symptoms and eliminates the need for supplemental courses of ingested glucocorticoids, Pulmonary function and height velocity of children receiving an inhaled glucocorticoid should be monitored at regular intervals.
引用
收藏
页码:S77 / S84
页数:8
相关论文
共 77 条
[21]   TREATMENT OF CHILDHOOD ASTHMA FOR 13 MONTHS AND LONGER WITH BECLOMETHASONE DIPROPIONATE AEROSOL [J].
GODFREY, S ;
KONIG, P .
ARCHIVES OF DISEASE IN CHILDHOOD, 1974, 49 (08) :591-596
[22]  
GROSS G, 1997, AM J RESP CRIT CARE, V155, pA666
[23]   COMPARISON OF THE EFFICACY AND SAFETY OF INHALED FLUTICASONE PROPIONATE 200 MU-G DAY WITH INHALED BECLOMETHASONE DIPROPIONATE 400 MU-G DAY IN MILD AND MODERATE ASTHMA [J].
GUSTAFSSON, P ;
TSANAKAS, J ;
GOLD, M ;
PRIMHAK, R ;
RADFORD, M ;
GILLIES, E .
ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (02) :206-211
[24]   CROSS-SECTIONAL STUDY OF BONE-DENSITY IN ASTHMATIC-CHILDREN [J].
HOPP, RJ ;
DEGAN, JA ;
PHELAN, J ;
LAPPE, J ;
GALLAGHER, GC .
PEDIATRIC PULMONOLOGY, 1995, 20 (03) :189-192
[25]  
HUNT GJJ, 1994, THORAX, V49, pP399
[26]  
Inoue T, 1995, Arerugi, V44, P678
[27]   SLIGHT STEROID-SPARING EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN CHILDREN AND ADOLESCENTS WITH MODERATELY SEVERE BRONCHIAL-ASTHMA [J].
JAKOBSSON, T ;
CRONER, S ;
KJELLMAN, NIM ;
PETTERSSON, A ;
VASSELLA, C ;
BJORKSTEN, B .
ALLERGY, 1994, 49 (06) :413-420
[28]   Issues in the use of inhaled glucocorticoids [J].
Kamada, AK ;
Szefler, SJ ;
Martin, RJ ;
Boushey, HA ;
Chinchilli, VM ;
Drazen, JM ;
Fish, JE ;
Israel, E ;
Lazarus, SC ;
Lemanske, RF ;
Cherniak, RM ;
Hurd, SS ;
Peters, SP ;
Sorkness, C ;
Szefler, SJ ;
Zwillich, CW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (06) :1739-1748
[29]  
KATZ Y, 1996, AM J RESP CRIT CAR S, V156, pA74
[30]   EFFECT OF LONG-TERM TREATMENT WITH INHALED CORTICOSTEROIDS AND BETA-AGONISTS ON THE BRONCHIAL RESPONSIVENESS IN CHILDREN WITH ASTHMA [J].
KERREBIJN, KF ;
VANESSENZANDVLIET, EEM ;
NEIJENS, HJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (04) :653-659